Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 43,03€(+16,42%). Der Median liegt bei 43,03€(+16,42%).
Kaufen | 13 |
Halten | 13 |
Verkaufen | 0 |
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that plans are advancing to launch three new sample preparation instruments during 2025 and 2026 to expand and strengthen its portfolio for automated sample preparation. These systems are designed to deliver new levels of efficiency and sustainability for laboratories worldwide and address different customer segments: QIAsymphony Connect, which marks the next generation of the flagship QIAsym.» Mehr auf businesswire.com
QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast
VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the first quarter 2025. Press release date / time: Wednesday, May 7, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time. Conference call date / time: Thursday, May 8, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time. Three options for joining the conference call Register for call back connection - Click here: Connect.» Mehr auf businesswire.com
QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced preliminary Q1 2025 results that exceeded its outlook for both net sales and adjusted earnings per share (EPS), reflecting strong performances across many growth drivers. Net sales grew approximately 5% (+7% at constant exchange rates, CER) to about $483 million in Q1 2025, surpassing the previously communicated outlook for about 3% CER growth (4% CER core business excluding discontinued.» Mehr auf businesswire.com
Unternehmenszahlen
(EUR) | Dez. 2024 | |
---|---|---|
Umsatz | 500,88 Mio | 8,75% |
Bruttoeinkommen | 336,16 Mio | 7,67% |
Nettoeinkommen | 84,88 Mio | 3,93% |
EBITDA | 182,32 Mio | 10,20% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 7,88 Mrd€ |
Anzahl Aktien | 216,12 Mio |
52 Wochen-Hoch/Tief | 42,09€ - 33,05€ |
Dividenden | Nein |
Beta | 0,62 |
KGV (PE Ratio) | 107,37 |
KGWV (PEG Ratio) | −14,67 |
KBV (PB Ratio) | 2,52 |
KUV (PS Ratio) | 4,54 |
Unternehmensprofil
Name | Qiagen NV |
CEO | Thierry Bernard |
Mitarbeiter | 5.067 |
Assets entdecken
Shareholder von Qiagen NV investieren auch in folgende Assets